Improved Isolation of Marine Natural Products

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$75,000.00
Award Year:
1994
Program:
SBIR
Phase:
Phase I
Contract:
1 R43 CA64017-1,
Agency Tracking Number:
24881
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
Aphios Corp.
3-E Gill Street, Woburn, MA, 01801
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
Trevor Castor
(617) 932-6933
Business Contact:
() -
Research Institution:
n/a
Abstract
The overall goal of this R&D program is to develop improved methodologies and manufacturingprocesses for the isolation of marine natural products with anticancer or anti-HIV activity. Thetherapeutic potential of marine natural products has rapidly advanced in recent years. One suchpotential therapeutic is bryostatin I which is derived from the marine bryozoan Bugula neritana. Whileharvesting the bryozoan with consistent sources of the active agent will become a significant portionof the supply problem, large-scale manufacturing of the natural product agent will also pose significantchallenges to processing logistics and manufacturing costs. Our specific aim is to investigate theapplication of supercritical fluid extraction and chromatography for the isolation and purification ofbryostatin I since these techniques have shown promise for the large scale manufacturing of certainanti-cancer agents such as taxol from terrestrial biomass sources. In this effort, we plan to collaboratewith CalBioMarine who will supply both naturally occurring and aquacultured quantities of B. neritina.This investigation should lead to the establishment of improved manufacturing processes for producinglarge quantities of marine natural product agents needed for preclinical and clinical development.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government